JANLYN ANTHONY: Open Payments
NPI 1295757805 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,713 in 199 payments from 17 companies in 2025. Trend: 2023 $3,039 · 2024 $3,869 · 2025 $4,713
Food & beverage: $4,602Education: $111
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 23 | $773 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 32 | $771 |
| E.R. Squibb & Sons, L.L.C. | 13 | $440 |
| Alkermes, Inc. | 18 | $427 |
| ABBVIE INC. | 19 | $395 |
| Neurocrine BioSciences, Inc. | 26 | $363 |
| Otsuka America Pharmaceutical, Inc. | 11 | $308 |
| Bausch Health US, LLC | 11 | $236 |
| Teva Pharmaceuticals USA, Inc. | 12 | $216 |
| Axsome Therapeutics, Inc. | 6 | $196 |
Products named: CAPLYTA, FANAPT, COBENFY, ARISTADA, VRAYLAR, INGREZZA, REXULTI, APLENZIN.
Industry payments across VA — which companies pay providers there.
